Faeth Therapeutics Inc. (FTH)
FTH trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$21.51
-7.48% on the day
Market cap
$555.8M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | FTH on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001829802 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-06-18 |
| Latest annual report | 10-K/A | 2026-06-02 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-09-17 |
| Latest proxy | DEFA14A | 2026-05-22 |
Source: SEC EDGAR submissions feed, 445 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -19.0% |
| 1 month | -43.0% |
| 3 months | -22.2% |
| Year to date | +89.1% |
| 1 year | +71.1% |
| From 52-week high | -49.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SLN | Silence Therapeutics Plc American Depository Share | $8.87 | -8.08% | $551.3M |
| STTK | Shattuck Labs Inc. | $5.49 | -9.85% | $551.0M |
| SGMT | Sagimet Biosciences Inc. Series A | $7.98 | -9.32% | $562.9M |
| PHAT | Phathom Pharmaceuticals Inc. | $7.00 | -1.82% | $566.3M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
| PBYI | Puma Biotechnology Inc | $10.12 | -1.65% | $522.4M |
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier